The global digital polymerase chain reaction (dPCR) market will grow rapidly at 10.1% CAGR during the forecast period, primarily due to an increase in the number of applications where dPCR is employed. dPCR is widely used in applications such as high-precision copy number variation (CNV), rare mutation analysis, viral load qualification, and differential gene expression. Also, another major factor driving the demand for dPCR solutions is an increase in the number of chronic cases globally, driving the need for faster detection and drug development that is carried out using several methods, including dPCR. The presence of a large number of biotechnology and pharmaceutical companies in the Americas has made it the largest market, as these companies use dPCR solutions to test and develop drugs for various purposes. dPCR technologies that are also widely used in drug discovery and clinical testing processes are increasing by the day as a result of the global pharmaceutical industry recovering its growth. Hence, the demand for dPCR solutions is likely to rise with it.

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by product type

Market overview

PART 07: Market segmentation by geography

Market overview

PART 08: Decision framework

PART 09: Drivers and challenges

Market drivers

Impact of drivers on key customer segments

Market challenges

Impact of challenges on key customer segments

PART 10: Market trends

PART 11: Vendor landscape

Competitive scenario

PART 12: Key vendor analysis

Bio-Rad Laboratories

Fluidigm

RainDance Technologies

Thermo Fisher Scientific

Other prominent vendors

PART 13: Appendix

List of abbreviations

PART 14: Explore Technavio